To validate our finding that the 5 markers are indeed downstream targets of STAT1 in ESCC tumors, we performed immunohistochemistry to assess the expression of these proteins and correlated the results with STAT1 expression in a cohort of ESCC primary tumors (n = 62). The gene discussed is STAT1; the disease is esophageal squamous cell carcinoma.